All

What are you looking for?

All
Projects
Results
Organizations

Quick search

  • Projects supported by TA ČR
  • Excellent projects
  • Projects with the highest public support
  • Current projects

Smart search

  • That is how I find a specific +word
  • That is how I leave the -word out of the results
  • “That is how I can find the whole phrase”

Host-pathogen interactions during hepatitis B virus infection

The result's identifiers

  • Result code in IS VaVaI

    <a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F61388963%3A_____%2F25%3A00645520" target="_blank" >RIV/61388963:_____/25:00645520 - isvavai.cz</a>

  • Result on the web

    <a href="https://hdl.handle.net/11104/0375312" target="_blank" >https://hdl.handle.net/11104/0375312</a>

  • DOI - Digital Object Identifier

Alternative languages

  • Result language

    angličtina

  • Original language name

    Host-pathogen interactions during hepatitis B virus infection

  • Original language description

    Hepatitis B virus (HBV) is a human pathogen that causes serious liver diseases including hepatocellular carcinoma. While vaccination effectively prevents new infections, there is a need for improved therapies for chronic HBV. To develop novel effective treatments, it is crucial to understand the interactions between the virus and the host cells. We aimed to identify HBV-induced proteomic changes in human hepatocytes following in vitro infection and to identify host factors that regulate HBV replication. We used label-free differential proteomics and data-independent acquisition mass spectrometry to quantify proteins in naïve and HBV-infected primary human hepatocytes (PHH) and corresponding culture fluids. We used the selective HBV entry inhibitor bulevirtide to distinguish specific viral effects from non-specific inoculum effects. To analyze the role of selected cellular proteins in HBV replication, we evaluated the effect of RNA silencing on HBV infection in human hepatoblastoma HepG2-NTCP cells, primary human hepatocytes and HepG2.2.15 cells—a subclone of HepG2 cells that stably express the hepatitis B virus. We have quantified over 5900 proteins and identified HBV-induced proteomic changes after HBV infection in vitro. We found that the majority of changes can be attributed to non-viral components of the inoculum and identified protein changes induced by the productive HBV infection. We also analyzed how the secretory carrier membrane proteins (SCAMP) regulate HBV infection. The SCAMP protein family consists of proteins involved in the regulation of membrane trafficking processes. Silencing of SCAMP3 significantly reduced HBV RNA production and antigen secretion in HepG2-NTCP and PHH cells but had no effect in HepG2.2.15 cells. These results suggest that SCAMP3 is involved in early infection.nThis work was supported by the project National Institute of Virology and Bacteriology (Programme EXCELES, ID Project No. LX22NPO5103) – Funded by the European Union – NextGenerationEU.

  • Czech name

  • Czech description

Classification

  • Type

    O - Miscellaneous

  • CEP classification

  • OECD FORD branch

    10608 - Biochemistry and molecular biology

Result continuities

  • Project

    <a href="/en/project/LX22NPO5103" target="_blank" >LX22NPO5103: National Institute of Virology and Bacteriology</a><br>

  • Continuities

    I - Institucionalni podpora na dlouhodoby koncepcni rozvoj vyzkumne organizace

Others

  • Publication year

    2025

  • Confidentiality

    S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů